U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 578

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr5:149360488
GRCh38:
Chr5:149980925
SLC26A2Multiple epiphyseal dysplasia type 4, Achondrogenesis, type IB, Diastrophic dysplasia,
Atelosteogenesis type II
Likely benign
(Oct 12, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr5:149357216-149361376
SLC26A2Achondrogenesis, type IB, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Diastrophic dysplasia
Pathogenic
(Aug 28, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr5:149357626
GRCh38:
Chr5:149978063
SLC26A2Multiple epiphyseal dysplasia type 4, Achondrogenesis, type IB, Diastrophic dysplasia,
Atelosteogenesis type II
Likely benign
(Oct 5, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr5:149360353
GRCh38:
Chr5:149980790
SLC26A2Multiple epiphyseal dysplasia type 4, Achondrogenesis, type IB, Diastrophic dysplasia,
Atelosteogenesis type II
Likely benign
(Sep 27, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr5:149360081
GRCh38:
Chr5:149980518
SLC26A2L309FAchondrogenesis, type IB, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Diastrophic dysplasia
Uncertain significance
(Oct 16, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr5:149357783
GRCh38:
Chr5:149978220
SLC26A2S190GAchondrogenesis, type IB, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Diastrophic dysplasia
Uncertain significance
(Jul 28, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr5:149360603
GRCh38:
Chr5:149981040
SLC26A2L483FAchondrogenesis, type IB, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Diastrophic dysplasia
Uncertain significance
(Jul 15, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr5:149359935
GRCh38:
Chr5:149980372
SLC26A2A260VAchondrogenesis, type IB, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Diastrophic dysplasia
Uncertain significance
(Feb 16, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr5:149360953
GRCh38:
Chr5:149981390
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4,
Diastrophic dysplasia
Likely benign
(Aug 21, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr5:149359862
GRCh38:
Chr5:149980299
SLC26A2M236VDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Jun 27, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr5:149357842
GRCh38:
Chr5:149978279
SLC26A2D209EDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Sep 24, 2021)
criteria provided, single submitter
12.
GRCh37:
Chr5:149357850
GRCh38:
Chr5:149978287
SLC26A2C212FDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Jun 19, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr5:149360975
GRCh38:
Chr5:149981412
SLC26A2I607VDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Mar 26, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr5:149360697
GRCh38:
Chr5:149981134
SLC26A2I514TDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Jun 21, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr5:149360826
GRCh38:
Chr5:149981263
SLC26A2V557ADiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB, Inborn genetic diseases
Uncertain significance
(May 9, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr5:149360995-149360997
GRCh38:
Chr5:149981432-149981434
SLC26A2K615delDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Jan 11, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr5:149360089
GRCh38:
Chr5:149980526
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(May 15, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr5:149360561
GRCh38:
Chr5:149980998
SLC26A2L469VDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Feb 14, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr5:149357284
GRCh38:
Chr5:149977721
SLC26A2P24fsDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Pathogenic
(Sep 28, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr5:149360608
GRCh38:
Chr5:149981045
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Sep 26, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr5:149361148
GRCh38:
Chr5:149981585
SLC26A2I664MDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Jun 14, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr5:149360895
GRCh38:
Chr5:149981332
SLC26A2I580TDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Aug 16, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr5:149361221
GRCh38:
Chr5:149981658
SLC26A2T689ADiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Jul 26, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr5:149357749
GRCh38:
Chr5:149978186
SLC26A2Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II,
Multiple epiphyseal dysplasia type 4
Likely benign
(Jul 6, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr5:149357289
GRCh38:
Chr5:149977726
SLC26A2S25CDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Dec 20, 2021)
criteria provided, single submitter
26.
GRCh37:
Chr5:149360420
GRCh38:
Chr5:149980857
SLC26A2G422SDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Apr 29, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr5:149357910
GRCh38:
Chr5:149978347
SLC26A2Y232CDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Jun 22, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr5:149360642
GRCh38:
Chr5:149981079
SLC26A2R496CDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Feb 5, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr5:149361292
GRCh38:
Chr5:149981729
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(May 1, 2020)
criteria provided, single submitter
30.
GRCh37:
Chr5:149357287
GRCh38:
Chr5:149977724
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Sep 19, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr5:149360271
GRCh38:
Chr5:149980708
SLC26A2K372RDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(May 10, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr5:149360196
GRCh38:
Chr5:149980633
SLC26A2S347FDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Sep 2, 2021)
criteria provided, single submitter
33.
GRCh37:
Chr5:149360720
GRCh38:
Chr5:149981157
SLC26A2S522PDiastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Achondrogenesis, type IB
Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
34.
GRCh37:
Chr5:149361095
GRCh38:
Chr5:149981532
SLC26A2H647YAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4, Inborn genetic diseases
Uncertain significance
(Jan 17, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr5:149357310
GRCh38:
Chr5:149977747
SLC26A2Q32LAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Aug 9, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr5:149360637
GRCh38:
Chr5:149981074
SLC26A2A494VAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Apr 21, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr5:149357377
GRCh38:
Chr5:149977814
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(May 9, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr5:149360938
GRCh38:
Chr5:149981375
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Dec 21, 2021)
criteria provided, single submitter
39.
GRCh37:
Chr5:149360595
GRCh38:
Chr5:149981032
SLC26A2K480RAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Jan 22, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr5:149361167
GRCh38:
Chr5:149981604
SLC26A2R671CInborn genetic diseases, Achondrogenesis, type IB, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II
Uncertain significance
(Jan 23, 2023)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr5:149360593
GRCh38:
Chr5:149981030
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Oct 2, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr5:149357767
GRCh38:
Chr5:149978204
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Oct 28, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr5:149361054
GRCh38:
Chr5:149981491
SLC26A2D633VAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Aug 22, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr5:149360146-149360148
GRCh38:
Chr5:149980583-149980585
SLC26A2A331delAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Mar 11, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr5:149361302
GRCh38:
Chr5:149981739
SLC26A2M716VAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Nov 1, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr5:149360880
GRCh38:
Chr5:149981317
SLC26A2K575RAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Jan 15, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr5:149361174
GRCh38:
Chr5:149981611
SLC26A2D673VAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
48.
GRCh37:
Chr5:149357684
GRCh38:
Chr5:149978121
SLC26A2S157TAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Jul 7, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr5:149361241-149361242
GRCh38:
Chr5:149981678-149981679
SLC26A2N696fsAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Pathogenic
(Apr 26, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr5:149360440
GRCh38:
Chr5:149980877
SLC26A2Achondrogenesis, type IB, Multiple epiphyseal dysplasia type 4, Diastrophic dysplasia,
Atelosteogenesis type II
Likely benign
(Apr 24, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr5:149361103
GRCh38:
Chr5:149981540
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Apr 11, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr5:149360705
GRCh38:
Chr5:149981142
SLC26A2V517LAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Apr 1, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr5:149357506
GRCh38:
Chr5:149977943
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Mar 24, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr5:149357845
GRCh38:
Chr5:149978282
SLC26A2R210SAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Mar 20, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr5:149360486
GRCh38:
Chr5:149980923
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Mar 15, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr5:149357333
GRCh38:
Chr5:149977770
SLC26A2K40*Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Pathogenic
(Mar 13, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr5:149357429
GRCh38:
Chr5:149977866
SLC26A2K72*Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Pathogenic
(Sep 16, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr5:149359995-149359996
GRCh38:
Chr5:149980432-149980433
SLC26A2N281*Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Pathogenic
(Feb 20, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr5:149360955-149360958
GRCh38:
Chr5:149981392-149981395
SLC26A2Q602fsAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Pathogenic
(Feb 17, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr5:149360989
GRCh38:
Chr5:149981426
SLC26A2Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II,
Multiple epiphyseal dysplasia type 4
Likely benign
(Feb 24, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr5:149360662
GRCh38:
Chr5:149981099
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Feb 6, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr5:149360710
GRCh38:
Chr5:149981147
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Feb 4, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr5:149357420
GRCh38:
Chr5:149977857
SLC26A2F69LAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Feb 4, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr5:149359848
GRCh38:
Chr5:149980285
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Oct 8, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr5:149360136
GRCh38:
Chr5:149980573
SLC26A2S327FAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Jun 9, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr5:149360923
GRCh38:
Chr5:149981360
SLC26A2Y589*Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Pathogenic
(Jan 17, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr5:149357832
GRCh38:
Chr5:149978269
SLC26A2H206RAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Aug 21, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr5:149361280
GRCh38:
Chr5:149981717
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Feb 17, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr5:149357775
GRCh38:
Chr5:149978212
SLC26A2N187SAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Mar 12, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr5:149360257
GRCh38:
Chr5:149980694
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4,
Diastrophic dysplasia
Likely benign
(Jan 1, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr5:149357585
GRCh38:
Chr5:149978022
SLC26A2P124TAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Dec 28, 2021)
criteria provided, single submitter
72.
GRCh37:
Chr5:149357332
GRCh38:
Chr5:149977769
SLC26A2F39LAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Mar 12, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr5:149361216
GRCh38:
Chr5:149981653
SLC26A2N687SAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Oct 14, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr5:149357596
GRCh38:
Chr5:149978033
SLC26A2I127MAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Dec 23, 2021)
criteria provided, single submitter
75.
GRCh37:
Chr5:149357865
GRCh38:
Chr5:149978302
SLC26A2Y217CInborn genetic diseases, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4, Achondrogenesis, type IB
Uncertain significance
(May 30, 2023)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr5:149361370-149361377
GRCh38:
Chr5:149981807-149981814
SLC26A2D739fsAchondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Jun 29, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr5:149361193
GRCh38:
Chr5:149981630
SLC26A2I679MAtelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Aug 15, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr5:149357380
GRCh38:
Chr5:149977817
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Dec 17, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr5:149360572
GRCh38:
Chr5:149981009
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Dec 25, 2021)
criteria provided, single submitter
80.
GRCh37:
Chr5:149360421
GRCh38:
Chr5:149980858
SLC26A2G422AAtelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Aug 31, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr5:149360785
GRCh38:
Chr5:149981222
SLC26A2L544fsAtelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Pathogenic
(Apr 8, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr5:149360020
GRCh38:
Chr5:149980457
SLC26A2Achondrogenesis, type IB, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II,
Diastrophic dysplasia
Likely benign
(May 29, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr5:149360530
GRCh38:
Chr5:149980967
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Oct 14, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr5:149360521
GRCh38:
Chr5:149980958
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Oct 9, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr5:149361106
GRCh38:
Chr5:149981543
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Likely benign
(Oct 3, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr5:149357319
GRCh38:
Chr5:149977756
SLC26A2S35*Atelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Pathogenic
(Sep 30, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr5:149360509
GRCh38:
Chr5:149980946
SLC26A2Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II,
Multiple epiphyseal dysplasia type 4
Likely benign
(Sep 3, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr5:149357773
GRCh38:
Chr5:149978210
SLC26A2Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II,
Multiple epiphyseal dysplasia type 4
Likely benign
(Sep 1, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr5:149357605
GRCh38:
Chr5:149978042
SLC26A2Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II,
Multiple epiphyseal dysplasia type 4
Likely benign
(Aug 30, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr5:149361264
GRCh38:
Chr5:149981701
SLC26A2E704fsAtelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Pathogenic
(Aug 25, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr5:149360797
GRCh38:
Chr5:149981234
SLC26A2Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II,
Multiple epiphyseal dysplasia type 4
Likely benign
(Aug 23, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr5:149360812
GRCh38:
Chr5:149981249
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4,
Diastrophic dysplasia
Likely benign
(Aug 20, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr5:149357635
GRCh38:
Chr5:149978072
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4,
Diastrophic dysplasia
Likely benign
(Dec 2, 2021)
criteria provided, single submitter
94.
GRCh37:
Chr5:149360386
GRCh38:
Chr5:149980823
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4,
Diastrophic dysplasia
Likely benign
(Aug 16, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr5:149361034
GRCh38:
Chr5:149981471
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4,
Diastrophic dysplasia
Likely benign
(Mar 20, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr5:149357866
GRCh38:
Chr5:149978303
SLC26A2Achondrogenesis, type IB, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4,
Diastrophic dysplasia
Likely benign
(Jul 10, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr5:149360499
GRCh38:
Chr5:149980936
SLC26A2S448*Atelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Pathogenic
(Jul 6, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr5:149361169
GRCh38:
Chr5:149981606
SLC26A2Multiple epiphyseal dysplasia type 4, Achondrogenesis, type IB, Diastrophic dysplasia,
Atelosteogenesis type II
Likely benign
(Jun 22, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr5:149357825
GRCh38:
Chr5:149978262
SLC26A2L204VAtelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Uncertain significance
(Jun 17, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr5:149360584
GRCh38:
Chr5:149981021
SLC26A2Y476*Atelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia,
Multiple epiphyseal dysplasia type 4
Pathogenic
(Jun 3, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination